Guanfacine in Comorbid ADHD & Tourette’s Syndrome

Guanfacine in Comorbid ADHD & Tourette’s Syndrome

An open-label study of guanfacine (1.5 mg/d), an a-adrenergic agonist, in 10 children with TS + ADHD, aged 8 to 16 years, was reported from the Yale University School of Medicine, New Haven, CT, and Johns Hopkins Medical Institutions, Baltimore, MD.

Bibliographic Details
Main Author: J Gordon Millichap
Format: Article
Language:English
Published: Pediatric Neurology Briefs Publishers 1995-09-01
Series:Pediatric Neurology Briefs
Subjects:
open-label study
commission errors
phonic tics
Online Access:https://www.pediatricneurologybriefs.com/articles/2572
id doaj-228ba84e1bbb411db8fc18fe53edaded
record_format Article
spelling doaj-228ba84e1bbb411db8fc18fe53edaded2020-11-25T01:01:03ZengPediatric Neurology Briefs PublishersPediatric Neurology Briefs1043-31552166-64821995-09-0199666710.15844/pedneurbriefs-9-9-32559Guanfacine in Comorbid ADHD & Tourette’s SyndromeJ Gordon Millichap0Northwestern University Feinberg School of MedicineAn open-label study of guanfacine (1.5 mg/d), an a-adrenergic agonist, in 10 children with TS + ADHD, aged 8 to 16 years, was reported from the Yale University School of Medicine, New Haven, CT, and Johns Hopkins Medical Institutions, Baltimore, MD.https://www.pediatricneurologybriefs.com/articles/2572open-label studycommission errorsphonic tics
collection DOAJ
language English
format Article
sources DOAJ
author J Gordon Millichap
spellingShingle J Gordon Millichap
Guanfacine in Comorbid ADHD & Tourette’s Syndrome
Pediatric Neurology Briefs
open-label study
commission errors
phonic tics
author_facet J Gordon Millichap
author_sort J Gordon Millichap
title Guanfacine in Comorbid ADHD & Tourette’s Syndrome
title_short Guanfacine in Comorbid ADHD & Tourette’s Syndrome
title_full Guanfacine in Comorbid ADHD & Tourette’s Syndrome
title_fullStr Guanfacine in Comorbid ADHD & Tourette’s Syndrome
title_full_unstemmed Guanfacine in Comorbid ADHD & Tourette’s Syndrome
title_sort guanfacine in comorbid adhd & tourette’s syndrome
publisher Pediatric Neurology Briefs Publishers
series Pediatric Neurology Briefs
issn 1043-3155
2166-6482
publishDate 1995-09-01
description An open-label study of guanfacine (1.5 mg/d), an a-adrenergic agonist, in 10 children with TS + ADHD, aged 8 to 16 years, was reported from the Yale University School of Medicine, New Haven, CT, and Johns Hopkins Medical Institutions, Baltimore, MD.
topic open-label study
commission errors
phonic tics
url https://www.pediatricneurologybriefs.com/articles/2572
work_keys_str_mv AT jgordonmillichap guanfacineincomorbidadhdtourettessyndrome
_version_ 1725211131907145728

Similar Items